Literature DB >> 8554946

Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test.

T Tateishi, S G Graham, Y Krivoruk, A J Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8554946      PMCID： PMC1365163          DOI： 10.1111/j.1365-2125.1995.tb04566.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist.

Authors:  R F Schafers; H L Elliott; C A Howie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Authors:  B Wallmark; P Lorentzon; H Larsson
Journal:  Scand J Gastroenterol Suppl       Date:  1985

3.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

Authors:  P B Watkins; S A Murray; L G Winkelman; D M Heuman; S A Wrighton; P S Guzelian
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  The erythromycin breath test as a predictor of cyclosporine blood levels.

Authors:  P B Watkins; T A Hamilton; T M Annesley; C N Ellis; J C Kolars; J J Voorhees
Journal:  Clin Pharmacol Ther       Date:  1990-08       Impact factor: 6.875

5.  Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test.

Authors:  Y Krivoruk; M T Kinirons; A J Wood; M Wood
Journal:  Clin Pharmacol Ther       Date:  1994-12       Impact factor: 6.875

Review 6.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

7.  Oral phenytoin pharmacokinetics during omeprazole therapy.

Authors:  P J Prichard; R P Walt; G K Kitchingman; K W Somerville; M J Langman; J Williams; A Richens
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 8.  Omeprazole drug interaction studies.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

9.  Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450.

Authors:  S Rendić; F Kajfez; H H Ruf
Journal:  Drug Metab Dispos       Date:  1983 Mar-Apr       Impact factor: 3.922

10.  Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.

Authors:  T Andersson; J O Miners; M E Veronese; W Tassaneeyakul; W Tassaneeyakul; U A Meyer; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335
View more
  1 in total

Review 1.  Drug interactions with proton pump inhibitors.

Authors:  P Unge; T Andersson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.